カテゴリ： MarketsandMarkets, 世界, 医療/バイオ

脊椎インプラントの世界市場予測（～2028）：製品別、用途別、手術別、地域別

■ 英語タイトル：Spinal Implants Market by Product (Devices (Thoracic, Cervical, Interbody Fusion, Spinal Non-Fusion), Biologics, Stimulators), Application (VCF, Spinal Decompression, Fusion, Non-Fusion), Surgery (Open, MIS), Region & Customer Unmet Need Forecast to 2028

調査会社MarketsandMarkets社が発行したリサーチレポート（データ管理コード：MD1173-24）■ 発行会社/調査会社：MarketsandMarkets
■ 商品コード：MD1173-24
■ 発行日：2024年1月25日
■ 調査対象地域：グローバル
■ 産業分野：医療機器
■ ページ数：322
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後24時間以内）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧）USD4,950 ⇒換算￥732,600見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算￥984,200見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算￥1,206,200見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※MarketsandMarkets社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[脊椎インプラントの世界市場予測（～2028）：製品別、用途別、手術別、地域別]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

“脊椎インプラントの世界市場は、2023年の112億米ドルから2028年には143億米ドルに達し、予測期間中のCAGRは5.0％で成長すると予測”脊椎インプラント市場の急成長が予測される背景には、魅力的な利点が数多くあります。特に、脊椎インプラントは、人口の高齢化、脊椎疾患の症例の増加、脊椎手術技術の進歩のための公的/民間組織による研究・資金提供イニシアチブの増加によって牽引されています。さらに、早期診断と早期治療の有効性が向上したことで、脊椎疾患の早期発見が増加しており、脊椎インプラントが最前線のソリューションとして位置づけられる先進的な治療方法に対する需要が高まっています。これらの要因により、市場は堅調な拡大局面を迎え、その結果、今後予測される数年間における脊椎インプラントの採用状況が形成されるものと思われます。

“2022-2028年に最大の市場シェアを記録する開腹手術セグメント”
手術の種類に基づき、脊椎インプラント市場は開放手術と低侵襲手術に区分されます。2022-2028年の予測期間で最大の市場シェアを記録したのは開腹手術セグメントです。このセグメントの成長は、重度の脊柱側弯症や高度な後弯症のような複雑な脊柱変形を伴う症例によるものです。開腹手術特有の直接的な可視化により、外科医は複雑な解剖学的異常に効果的に対処する能力が高まります。さらに、外科医が開腹手技に慣れ親しみ、専門的な知識を持っているかどうかが、手技の選択に影響することもあります。場合によっては、特に伝統的な手法の訓練を受けた外科医にとっては、開腹手術が好まれることもあり、このセグメントの進歩にさらに拍車をかけています。

“2022年の脊椎インプラント市場、エンドユーザー別では病院分野が最大シェア”
エンドユーザーに基づき、脊椎インプラント市場は病院と整形外科センターに区分されます。2022年には、病院セグメントが世界の脊椎インプラント市場で最大のシェアを占めました。このセグメントの成長は、日常的な処置から複雑な介入に至るまで脊椎手術の大部分を占めること、高度な脊椎インプラント技術を早期に採用すること、臨床実践を通じてトレンドを形成することなどの要因によって推進されています。

“予測期間中、アジア太平洋が市場の大幅な成長率を記録”
予測期間2023年から2028年にかけて、APAC地域は予測期間中に市場で著しい成長率を記録する見込みです。アジア太平洋は、インド、中国、日本、オーストラリア、韓国、その他アジア太平洋で構成されています。アジア太平洋(APAC)は脊椎インプラントの市場成長率が大幅に上昇しています。この成長にはいくつかの原動力があります。
アジア太平洋市場は、医療インフラの強化を目的とした新興国の政府機関による投資の増加により成長を遂げています。さらに、独立整形外科センターの増加、患者数の増加、アジア太平洋で脊椎インプラント製品の提供を拡大する業界プレイヤーの戦略的イニシアティブも、この市場の利益となっています。

本レポートの主な参加企業の内訳は以下の通りです：

- 企業タイプ別 ティア1：5％、ティア2：34％、ティア3：21％
- 役職別 Cレベル：47％、ディレクターレベル：33％、その他：20％
- 地域別 北米：35％、ヨーロッパ：32％、アジア太平洋：25％、中南米：6％、中東・アフリカ：2％

この市場で著名な企業は、Medtronic (Ireland), Johnson & Johnson- Depuy Synthes (US), Stryker Corporation (US), NuVasive (US)などです。

調査範囲

- 本レポートでは、製品、手術の種類、用途、エンドユーザー、地域に基づいて脊椎インプラント市場を調査しています。
- 市場成長に影響を与える要因（促進要因、阻害要因、機会、課題など）を分析しました。
- 利害関係者向けに市場の機会と課題を評価し、市場リーダー向けに競争環境の詳細を提供します。
- 当レポートでは、脊椎インプラントの世界市場における成長動向、展望、貢献に関してミクロ市場を調査しています。
- 主要5地域に関して、市場セグメントの収益を予測しています。

レポート購入の主な利点

本レポートは、包括的なデータの徹底的な分析を通じて、脊椎インプラント市場における新規参入企業/市場リーダー/中小企業の投資評価の実行可能性を支援することで、強固なリスク評価を促進し、十分な情報に基づいた投資決定を可能にします。用途、エンドユーザー、地域の次元を包含する綿密な市場セグメンテーションにより、正確なセグメントターゲティングのためのテーラーメイドの洞察が得られます。また、極めて重要なトレンド、課題、成長触媒、展望を網羅的に評価することで、鋭い洞察力による戦略的意思決定を支援します。

本レポートは、以下のポイントに関する洞察を提供します：

- 脊椎インプラント市場の成長に影響を与える主な促進要因（脊椎疾患有病率の増加、世界的な高齢者人口の増加、脊椎手術技術の継続的進歩）、阻害要因（治療処置の高額費用、償還構造の不確実性）、機会（病院数および手術センター数の増加、新興市場は高成長の機会を提供）、課題（適切な医師の不足、限られた認知度）の分析しました。
- 製品開発/イノベーション： 脊椎インプラント市場における今後の技術、研究開発活動、新製品・サービス開始に関する詳細な洞察を提供します。
- 市場開発： 有利な市場に関する包括的情報 - 当レポートでは、様々な地域の脊椎インプラント市場を分析しています。
- 市場の多様化： 脊椎インプラント市場における新製品、未開拓地域、最近の開発、投資に関する詳細情報を記載しています。
- 競合評価： Medtronic (Ireland), Johnson & Johnson- Depuy Synthes (US), Stryker Corporation (US), NuVasive (US)などの主要企業の市場シェア、成長戦略、サービス内容を詳細に評価しています。

1.　序論
2.　調査方法
3.　エグゼクティブサマリー
4.　プレミアムインサイト
5.　市場概要
6.　世界の脊椎インプラント市場規模：製品別
7.　世界の脊椎インプラント市場規模：手術種類別
8.　世界の脊椎インプラント市場規模：用途別
9.　世界の脊椎インプラント市場規模：エンドユーザー別
10.　世界の脊椎インプラント市場規模：地域別
11.　競争状況
12.　企業情報
13.　付録

*** レポート目次（コンテンツ）***

1 INTRODUCTION 45
1.1 STUDY OBJECTIVES 45
1.2 MARKET DEFINITION 45
1.2.1 INCLUSIONS AND EXCLUSIONS 45
1.3 MARKET SCOPE 46
1.3.1 MARKETS COVERED 46
1.3.2 REGIONS COVERED 46
1.3.3 YEARS CONSIDERED 47
1.4 CURRENCY CONSIDERED 47
1.5 MARKET STAKEHOLDERS 47
1.6 SUMMARY OF CHANGES 48
1.6.1 RECESSION IMPACT 48
2 RESEARCH METHODOLOGY 49
2.1 RESEARCH DATA 49
2.2 RESEARCH DESIGN 50
2.2.1 SECONDARY RESEARCH 50
2.2.1.1 Key data from secondary sources 52
2.2.2 PRIMARY RESEARCH 52
2.2.2.1 Primary sources 52
2.2.2.2 Key industry insights 53
2.2.2.3 Breakdown of primaries 53
FIGURE 1 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY AND DEMAND-SIDE PARTICIPANTS 53
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 54
2.3 MARKET SIZE ESTIMATION 54
FIGURE 3 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 55
2.3.1 BOTTOM-UP APPROACH 55
2.3.1.1 Approach 1: Company revenue estimation approach 56
FIGURE 4 SPINAL IMPLANTS MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ESTIMATION) 56
2.3.1.2 Approach 2: Customer-based market estimation 56
FIGURE 5 SPINAL IMPLANTS MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH 57
2.3.1.3 Approach 3: Top-down approach 57
2.3.1.4 Approach 4: Primary interviews 57
FIGURE 6 TOP-DOWN APPROACH 57
2.4 DATA TRIANGULATION AND MARKET BREAKDOWN 59
FIGURE 7 DATA TRIANGULATION METHODOLOGY 59
2.5 MARKET SHARE ASSESSMENT 60
2.6 STUDY ASSUMPTIONS 60
2.7 RISK ASSESSMENT 60
TABLE 1 ASSOCIATED RISKS 60
2.8 RESEARCH LIMITATIONS 60
2.9 GROWTH RATE ASSUMPTIONS 61
2.10 RECESSION IMPACT 61
3 EXECUTIVE SUMMARY 62
FIGURE 8 SPINAL IMPLANTS MARKET, BY TYPE OF SURGERY, 2023 VS. 2028 (USD MILLION) 62
FIGURE 9 SPINAL IMPLANTS MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION) 63
FIGURE 10 SPINAL IMPLANTS MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION) 63
FIGURE 11 SPINAL IMPLANTS MARKET, BY END USER, 2023 VS. 2028 (USD MILLION) 64
FIGURE 12 SPINAL IMPLANTS MARKET: GEOGRAPHICAL SNAPSHOT 65
4 PREMIUM INSIGHTS 66
4.1 SPINAL IMPLANTS MARKET OVERVIEW 66
FIGURE 13 INCREASING INCIDENCE OF SPINAL DISORDERS TO DRIVE MARKET 66
4.2 SPINAL IMPLANTS MARKET: REGIONAL LANDSCAPE, 2023 VS. 2028 (USD MILLION) 66
FIGURE 14 NORTH AMERICA TO RETAIN LARGEST MARKET SHARE 66
4.3 NORTH AMERICA: SPINAL IMPLANTS MARKET, BY COUNTRY AND END USER, 2022 (USD MILLION) 67
FIGURE 15 US AND HOSPITALS HELD LARGEST MARKET SHARES IN 2022 67
4.4 SPINAL IMPLANTS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 67
FIGURE 16 CHINA TO REGISTER HIGHEST CAGR OVER FORECAST PERIOD 67
5 MARKET OVERVIEW 68
5.1 INTRODUCTION 68
FIGURE 17 SPINAL IMPLANTS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 68
5.1.1 DRIVERS 69
5.1.1.1 Innovation in spine surgery technologies 69
5.1.1.2 Increasing incidence of spinal disorders 69
5.1.1.3 Launch of advanced bone graft products 70
5.1.1.4 Increasing demand for MIS procedures 70
5.1.1.5 Growing funding and support for research 71
TABLE 2 RECENT FUNDING FOR R&D IN SPINAL IMPLANTS 71
5.1.2 RESTRAINTS 71
5.1.2.1 High procedural costs 71
5.1.2.2 Unfavorable regulatory processes and limited reimbursement 72
5.1.3 OPPORTUNITIES 72
5.1.3.1 Rising number of hospitals and surgical centers 72
5.1.3.2 Emerging markets 72
5.1.4 CHALLENGES 73
5.1.4.1 Lack of personnel and limited awareness & education for MIS 73
5.2 PORTER’S FIVE FORCES ANALYSIS 73
TABLE 3 SPINAL IMPLANTS MARKET: PORTER’S FIVE FORCES ANALYSIS 73
5.2.1 THREAT OF NEW ENTRANTS 73
5.2.2 THREAT OF SUBSTITUTES 74
5.2.3 BARGAINING POWER OF SUPPLIERS 74
5.2.4 BARGAINING POWER OF BUYERS 74
5.2.5 INTENSITY OF COMPETITIVE RIVALRY 74
5.3 REGULATORY ANALYSIS 74
5.3.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 74
TABLE 4 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 74
TABLE 5 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 75
TABLE 6 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 75
TABLE 7 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 76
TABLE 8 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 76
5.3.1.1 Key regulatory guidelines 76
5.3.1.1.1 US 76
TABLE 9 US FDA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 77
5.3.1.1.2 Europe 78
5.3.1.1.3 Japan 79
5.4 REIMBURSEMENT SCENARIO 79
TABLE 10 REIMBURSEMENT CODES FOR VARIOUS PROCEDURES 79
5.5 ECOSYSTEM/MARKET MAP 81
5.6 VALUE CHAIN ANALYSIS 81
5.6.1 RESEARCH & DEVELOPMENT 81
5.6.2 PROCUREMENT AND PRODUCT DEVELOPMENT 81
5.6.3 MARKETING, SALES AND DISTRIBUTION, AND POST-SALES SERVICES 82
FIGURE 18 SPINAL IMPLANTS MARKET: VALUE CHAIN ANALYSIS 82
5.7 SUPPLY CHAIN ANALYSIS 82
5.7.1 PROMINENT COMPANIES 82
5.7.2 SMALL & MEDIUM-SIZED COMPANIES 82
5.7.3 END USERS 83
FIGURE 19 SPINAL IMPLANTS MARKET: SUPPLY CHAIN ANALYSIS 83
5.8 PRICING ANALYSIS 83
FIGURE 20 AVERAGE SELLING PRICE OF SPINAL IMPLANTS, BY PRODUCT (FY 2021-2023) 83
FIGURE 21 AVERAGE SELLING PRICE TREND OF SPINAL IMPLANTS (2021-2023), BY REGION (USD) 84
5.9 PATENT ANALYSIS 85
FIGURE 22 PATENT DETAILS FOR SPINAL IMPLANTS (JANUARY 2013–DECEMBER 2023) 85
5.10 TRADE ANALYSIS 86
TABLE 11 IMPORT DATA FOR SPINAL IMPLANTS (HS CODE 9021), BY COUNTRY, 2018–2022 (USD THOUSAND) 86
TABLE 12 EXPORT DATA FOR SPINAL IMPLANTS (HS CODE 3822), BY COUNTRY, 2018–2022 (USD THOUSAND) 86
5.11 KEY CONFERENCES AND EVENTS, 2023–2024 87
TABLE 13 SPINAL IMPLANTS MARKET: DETAILED LIST OF KEY CONFERENCES AND EVENTS IN 2023–2024 87
5.12 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 88
FIGURE 23 EMERGING TRENDS AND OPPORTUNITIES AFFECTING FUTURE REVENUE MIX 88
5.13 KEY STAKEHOLDERS AND BUYING CRITERIA 88
5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS 88
TABLE 14 KEY REQUIREMENTS OF STAKEHOLDERS WHILE BUYING SPINAL IMPLANTS (%) 88
5.13.2 KEY STAKEHOLDERS BUYING CRITERIA 89
FIGURE 24 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF SPINAL IMPLANTS 89
TABLE 15 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR KEY PRODUCT SEGMENTS (%) 89
5.14 SPINAL IMPLANTS MARKET: RECESSION IMPACT 89
5.15 UNMET NEEDS AND KEY PAIN POINTS 90
TABLE 16 SPINAL IMPLANTS MARKET: UNMET CUSTOMER NEEDS AND KEY PAIN POINTS 90
6 SPINAL IMPLANTS MARKET, BY PRODUCT 91
6.1 INTRODUCTION 92
TABLE 17 SPINAL IMPLANTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 92
6.2 THORACIC & LUMBAR FUSION DEVICES 92
TABLE 18 THORACIC & LUMBAR FUSION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 93
TABLE 19 THORACIC & LUMBAR FUSION DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 93
6.2.1 THORACIC & LUMBAR FUSION DEVICES MARKET, BY APPLICATION 94
TABLE 20 THORACIC & LUMBAR FUSION DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 94
6.2.2 THORACIC & LUMBAR FUSION DEVICES MARKET, BY TYPE OF SURGERY 94
TABLE 21 THORACIC & LUMBAR FUSION DEVICES MARKET, BY TYPE OF SURGERY, 2021–2028 (USD MILLION) 94
6.2.3 POSTERIOR THORACIC & LUMBAR FUSION DEVICES 94
6.2.3.1 Posterior fusion devices to account for largest market share 94
TABLE 22 POSTERIOR THORACIC & LUMBAR FUSION DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 95
6.2.4 INTERBODY THORACIC & LUMBAR FUSION DEVICES 95
TABLE 23 INTERBODY THORACIC & LUMBAR FUSION DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 96
6.2.4.1 Interbody thoracic & lumbar fusion devices market, by approach 96
TABLE 24 INTERBODY THORACIC & LUMBAR FUSION DEVICES MARKET, BY APPROACH, 2021–2028 (USD MILLION) 96
6.2.4.1.1 Anterior lumbar interbody fusion devices 97
TABLE 25 ANTERIOR LUMBAR INTERBODY FUSION DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 97
6.2.4.1.2 Posterior lumbar interbody fusion devices 97
TABLE 26 POSTERIOR LUMBAR INTERBODY FUSION DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 98
6.2.4.1.3 Transforaminal lumbar interbody fusion devices 98
TABLE 27 TRANSFORAMINAL LUMBAR INTERBODY FUSION DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 99
6.2.4.1.4 Axial lumbar interbody fusion devices 99
TABLE 28 AXIAL LUMBAR INTERBODY FUSION DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 100
6.2.4.2 Interbody thoracic & lumbar fusion devices market, by material 100
TABLE 29 INTERBODY THORACIC & LUMBAR FUSION DEVICES MARKET, BY MATERIAL, 2021–2028 (USD MILLION) 100
6.2.4.2.1 Non-bone interbody fusion devices 100
TABLE 30 NON-BONE INTERBODY FUSION DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 101
6.2.4.2.2 Bone interbody fusion devices 101
TABLE 31 BONE INTERBODY FUSION DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 101
6.2.5 ANTERIOR THORACIC & LUMBAR FUSION DEVICES 102
6.2.5.1 Minimized impact, low chance of blood loss and infection to support demand 102
TABLE 32 ANTERIOR THORACIC & LUMBAR FUSION DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 102
6.3 CERVICAL FUSION DEVICES 103
TABLE 33 CERVICAL FUSION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 103
TABLE 34 CERVICAL FUSION DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 103
6.3.1 CERVICAL FUSION DEVICES MARKET, BY APPLICATION 104
TABLE 35 CERVICAL FUSION DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 104
6.3.2 CERVICAL FUSION DEVICES MARKET, BY TYPE OF SURGERY 104
TABLE 36 CERVICAL FUSION DEVICES MARKET, BY TYPE OF SURGERY, 2021–2028 (USD MILLION) 104
6.3.3 ANTERIOR CERVICAL FUSION DEVICES 104
TABLE 37 ANTERIOR CERVICAL FUSION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 105
TABLE 38 ANTERIOR CERVICAL FUSION DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 105
6.3.3.1 Anterior cervical plates 105
6.3.3.1.1 Anterior cervical plates to hold largest share of cervical fusion devices market 105
TABLE 39 ANTERIOR CERVICAL PLATES MARKET, BY REGION, 2021–2028 (USD MILLION) 106
6.3.3.2 Anterior cervical screw systems 106
6.3.3.2.1 Potential risk of injury to limit acceptance 106
TABLE 40 ANTERIOR CERVICAL SCREW SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION) 107
6.3.3.3 Cervical interbody fusion devices 107
6.3.3.3.1 Growing use of PEEK over titanium-based devices to support market growth 107
TABLE 41 CERVICAL INTERBODY FUSION DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 107
6.3.4 POSTERIOR CERVICAL FUSION DEVICES 108
TABLE 42 POSTERIOR CERVICAL FUSION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 108
TABLE 43 POSTERIOR CERVICAL FUSION DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 108
6.3.4.1 Posterior cervical plates 109
6.3.4.1.1 Plates to hold largest share of posterior cervical fusion devices 109
TABLE 44 POSTERIOR CERVICAL PLATES MARKET, BY REGION, 2021–2028 (USD MILLION) 109
6.3.4.2 Posterior cervical screws 109
6.3.4.2.1 Growing preference for screws over plates in some procedures to favor market growth 109
TABLE 45 POSTERIOR CERVICAL SCREWS MARKET, BY REGION, 2021–2028 (USD MILLION) 110
6.3.4.3 Posterior cervical rods 110
6.3.4.3.1 Advantages of newer screw-rod constructs to drive adoption 110
TABLE 46 POSTERIOR CERVICAL RODS MARKET, BY REGION, 2021–2028 (USD MILLION) 110
6.4 SPINE BIOLOGICS 110
TABLE 47 SPINE BIOLOGICS MARKET, BY TYPE, 2021–2028 (USD MILLION) 111
TABLE 48 SPINE BIOLOGICS MARKET, BY REGION, 2021–2028 (USD MILLION) 112
6.4.1 SPINE BIOLOGICS MARKET, BY APPLICATION 112
TABLE 49 SPINE BIOLOGICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 112
6.4.2 SPINE BIOLOGICS MARKET, BY TYPE OF SURGERY 112
TABLE 50 SPINE BIOLOGICS MARKET, BY TYPE OF SURGERY, 2021–2028 (USD MILLION) 112
6.4.3 DEMINERALIZED BONE MATRIX 113
6.4.3.1 DBM to hold largest share of spine biologics market 113
TABLE 51 DEMINERALIZED BONE MATRIX MARKET, BY REGION, 2021–2028 (USD MILLION) 113
6.4.4 BONE MORPHOGENETIC PROTEINS 113
6.4.4.1 Safety and effectiveness to drive adoption 113
TABLE 52 BONE MORPHOGENETIC PROTEINS MARKET, BY REGION, 2021–2028 (USD MILLION) 114
6.4.5 BONE SUBSTITUTES 114
6.4.5.1 Easy availability, low cost, and other advantages to support adoption 114
TABLE 53 BONE SUBSTITUTES MARKET, BY REGION, 2021–2028 (USD MILLION) 115
6.4.6 MACHINED BONES 115
6.4.6.1 Rising popularity of PEEK and titanium spaces to restrain usage 115
TABLE 54 MACHINED BONES MARKET, BY REGION, 2021–2028 (USD MILLION) 115
6.4.7 CELL-BASED MATRICES 116
6.4.7.1 Complications such as risk of infection and sensory loss to affect demand 116
TABLE 55 CELL-BASED MATRICES MARKET, BY REGION, 2021–2028 (USD MILLION) 116
6.4.8 ALLOGRAFT BONE 116
6.4.8.1 Lower chance of successful fusion to limit adoption 116
TABLE 56 ALLOGRAFT BONE MARKET, BY REGION, 2021–2028 (USD MILLION) 117
6.5 VCF TREATMENT DEVICES 117
TABLE 57 VCF TREATMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 117
TABLE 58 VCF TREATMENT DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 118
6.5.1 VCF TREATMENT DEVICES MARKET, BY APPLICATION 118
TABLE 59 VCF TREATMENT DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 118
6.5.2 VCF TREATMENT DEVICES MARKET, BY TYPE OF SURGERY 118
TABLE 60 VCF TREATMENT DEVICES MARKET, BY TYPE OF SURGERY, 2021–2028 (USD MILLION) 118
6.5.3 BALLOON KYPHOPLASTY DEVICES 119
6.5.3.1 Better surgical outcomes to ensure sustained demand 119
TABLE 61 BALLOON KYPHOPLASTY DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 119
6.5.4 VERTEBROPLASTY DEVICES 119
6.5.4.1 Chances of cement leakage to limit adoption 119
TABLE 62 VERTEBROPLASTY DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 120
6.6 SPINAL DECOMPRESSION DEVICES 120
TABLE 63 SPINAL DECOMPRESSION DEVICES MARKET, BY PROCEDURE, 2021–2028 (USD MILLION) 121
TABLE 64 SPINAL DECOMPRESSION DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 121
6.6.1 SPINAL DECOMPRESSION DEVICES MARKET, BY APPLICATION 122
TABLE 65 SPINAL DECOMPRESSION DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 122
6.6.2 SPINAL DECOMPRESSION DEVICES MARKET, BY TYPE OF SURGERY 122
TABLE 66 SPINAL DECOMPRESSION DEVICES MARKET, BY TYPE OF SURGERY, 2021–2028 (USD MILLION) 122
6.6.3 DISCECTOMY 122
6.6.3.1 Rising interest in microdiscectomy to support market growth 122
TABLE 67 SPINAL DECOMPRESSION DEVICES MARKET FOR DISCECTOMY, BY REGION, 2021–2028 (USD MILLION) 123
6.6.4 LAMINOPLASTY, LAMINECTOMY, AND LAMINOTOMY 123
6.6.4.1 Rising incidence of spinal stenosis to drive market 123
TABLE 68 SPINAL DECOMPRESSION DEVICES MARKET FOR LAMINOPLASTY, LAMINECTOMY, AND LAMINOTOMY, BY REGION, 2021–2028 (USD MILLION) 124
6.6.5 FORAMINOTOMY & FORAMINECTOMY 124
6.6.5.1 Growing preference for MIS treatment of cervical radiculopathy to support adoption 124
TABLE 69 SPINAL DECOMPRESSION DEVICES MARKET FOR FORAMINOTOMY & FORAMINECTOMY, BY REGION, 2021–2028 (USD MILLION) 125
6.6.6 FACETECTOMY 125
6.6.6.1 Rising awareness of MIS and risks of facetectomy to restrain growth 125
TABLE 70 SPINAL DECOMPRESSION DEVICES MARKET FOR FACETECTOMY, BY REGION, 2021–2028 (USD MILLION) 126
6.6.7 CORPECTOMY 126
6.6.7.1 Challenging procedures and inherent risks to affect demand 126
TABLE 71 SPINAL DECOMPRESSION DEVICES MARKET FOR CORPECTOMY, BY REGION, 2021–2028 (USD MILLION) 127
6.7 NON-FUSION DEVICES 127
TABLE 72 NON-FUSION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 127
TABLE 73 NON-FUSION DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 128
6.7.1 NON-FUSION DEVICES MARKET, BY APPLICATION 128
TABLE 74 NON-FUSION DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 128
6.7.2 NON-FUSION DEVICES MARKET, BY TYPE OF SURGERY 128
TABLE 75 NON-FUSION DEVICES MARKET, BY TYPE OF SURGERY, 2021–2028 (USD MILLION) 128
6.7.3 DYNAMIC STABILIZATION DEVICES 129
TABLE 76 DYNAMIC STABILIZATION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 129
TABLE 77 DYNAMIC STABILIZATION DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 129
6.7.3.1 Interspinous process spacers 129
6.7.3.1.1 Positive outcomes and outpatient procedures to drive demand 129
TABLE 78 INTERSPINOUS PROCESS SPACERS MARKET, BY REGION, 2021–2028 (USD MILLION) 130
6.7.3.2 Pedicle screw-based dynamic rod devices 130
6.7.3.2.1 Need for long-term safety and efficacy evidence to restrain adoption 130
TABLE 79 PEDICLE SCREW-BASED DYNAMIC ROD DEVICES, BY REGION, 2021–2028 (USD MILLION) 130
6.7.3.3 Facet replacement products 131
6.7.3.3.1 Positive clinical outcomes and rising interest from players to support growth 131
TABLE 80 FACET REPLACEMENT PRODUCTS MARKET, BY REGION, 2021–2028 (USD MILLION) 131
6.7.4 ARTIFICIAL DISCS 131
TABLE 81 ARTIFICIAL DISCS MARKET, BY TYPE, 2021–2028 (USD MILLION) 131
TABLE 82 ARTIFICIAL DISCS MARKET, BY REGION, 2021–2028 (USD MILLION) 132
6.7.4.1 Artificial cervical discs 132
6.7.4.1.1 Increasing adoption of artificial disc replacement to drive market 132
TABLE 83 ARTIFICIAL CERVICAL DISCS MARKET, BY REGION, 2021–2028 (USD MILLION) 132
6.7.4.2 Artificial lumbar discs 133
6.7.4.2.1 Limited evidence for effectiveness and possibility of complications to hinder growth 133
TABLE 84 ARTIFICIAL LUMBAR DISCS MARKET, BY REGION, 2021–2028 (USD MILLION) 133
6.7.5 ANNULUS REPAIR DEVICES 134
6.7.5.1 Rising target patient population to drive usage 134
TABLE 85 ANNULUS REPAIR DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 134
6.7.6 NUCLEAR DISC PROSTHESES 134
6.7.6.1 Nuclear disc prostheses to register high growth 134
TABLE 86 NUCLEAR DISC PROSTHESES MARKET, BY REGION, 2021–2028 (USD MILLION) 134
6.8 SPINE BONE STIMULATORS 135
TABLE 87 SPINE BONE STIMULATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 135
TABLE 88 SPINE BONE STIMULATORS MARKET, BY REGION, 2021–2028 (USD MILLION) 135
6.8.1 SPINE BONE STIMULATORS MARKET, BY APPLICATION 136
TABLE 89 SPINE BONE STIMULATORS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 136
6.8.2 SPINE BONE STIMULATORS MARKET, BY TYPE OF SURGERY 136
TABLE 90 SPINE BONE STIMULATORS MARKET, BY TYPE OF SURGERY, 2021–2028 (USD MILLION) 136
6.8.3 NONINVASIVE SPINE BONE STIMULATORS 136
TABLE 91 NONINVASIVE SPINE BONE STIMULATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 136
TABLE 92 NONINVASIVE SPINE BONE STIMULATORS MARKET, BY REGION, 2021–2028 (USD MILLION) 137
6.8.3.1 Pulsed electromagnetic field devices 137
6.8.3.2 CC & CMF devices 137
6.8.4 INVASIVE SPINE BONE STIMULATORS 138
6.8.4.1 Disadvantages and complications to affect pace of market growth 138
TABLE 93 INVASIVE SPINE BONE STIMULATORS MARKET, BY REGION, 2021–2028 (USD MILLION) 138
7 SPINAL IMPLANTS MARKET, BY TYPE OF SURGERY 139
7.1 INTRODUCTION 140
TABLE 94 SPINAL IMPLANTS MARKET, BY TYPE OF SURGERY, 2021–2028 (USD MILLION) 140
7.2 OPEN SURGERY 140
7.2.1 INCREASING PREFERENCE FOR OPEN SPINE SURGERIES TO DRIVE MARKET 140
TABLE 95 SPINAL IMPLANTS MARKET FOR OPEN SURGERY, BY REGION, 2021–2028 (USD MILLION) 141
7.3 MINIMALLY INVASIVE SURGERY 141
7.3.1 MINIMALLY INVASIVE SURGERY SEGMENT TO REGISTER HIGHEST GROWTH 141
TABLE 96 SPINAL IMPLANTS MARKET FOR MINIMALLY INVASIVE SURGERY, BY REGION, 2021–2028 (USD MILLION) 142
8 SPINAL IMPLANTS MARKET, BY APPLICATION 143
8.1 INTRODUCTION 144
TABLE 97 SPINAL IMPLANTS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 144
8.2 SPINAL FUSION & FIXATION 144
8.2.1 SPINAL FUSION & FIXATION TECHNOLOGIES TO DOMINATE MARKET OVER FORECAST PERIOD 144
TABLE 98 SPINAL IMPLANTS MARKET FOR SPINAL FUSION & FIXATION, BY REGION, 2021–2028 (USD MILLION) 145
8.3 VCF TREATMENT 145
8.3.1 INCREASING FRACTURE INCIDENCE TO SUPPORT MARKET GROWTH 145
TABLE 99 SPINAL IMPLANTS MARKET FOR VCF TREATMENT, BY REGION, 2021–2028 (USD MILLION) 146
8.4 MOTION PRESERVATION/NON-FUSION 146
8.4.1 MOTION PRESERVATION/NON-FUSION TECHNOLOGIES TO WITNESS HIGHEST GROWTH 146
TABLE 100 SPINAL IMPLANTS MARKET FOR MOTION PRESERVATION/NON-FUSION, BY REGION, 2021–2028 (USD MILLION) 147
8.5 SPINAL DECOMPRESSION 147
8.5.1 RISING INCIDENCE OF SPINAL TUMORS AND DEVELOPMENT OF MINIMALLY INVASIVE DEVICES TO DRIVE MARKET 147
TABLE 101 SPINAL IMPLANTS MARKET FOR SPINAL DECOMPRESSION, BY REGION, 2021–2028 (USD MILLION) 148
9 SPINAL IMPLANTS MARKET, BY END USER 149
9.1 INTRODUCTION 150
TABLE 102 SPINAL IMPLANTS MARKET, BY END USER, 2021–2028 (USD MILLION) 150
9.2 HOSPITALS 150
9.2.1 HOSPITALS TO HOLD LARGEST MARKET SHARE 150
TABLE 103 SPINAL IMPLANTS MARKET FOR HOSPITALS, BY REGION, 2021–2028 (USD MILLION) 150
9.3 ORTHOPEDIC CENTERS 151
9.3.1 EARLY DETECTION OF SPINAL DISORDERS AND LOWER TURNAROUND TIME TO DRIVE MARKET 151
TABLE 104 SPINAL IMPLANTS MARKET FOR ORTHOPEDIC CENTERS, BY REGION, 2021–2028 (USD MILLION) 151
10 SPINAL IMPLANTS MARKET, BY REGION 152
10.1 INTRODUCTION 153
TABLE 105 SPINAL IMPLANTS MARKET, BY REGION, 2021–2028 (USD MILLION) 153
10.2 NORTH AMERICA 153
10.2.1 NORTH AMERICA: RECESSION IMPACT 153
FIGURE 25 NORTH AMERICA: MARKET SNAPSHOT 154
TABLE 106 NORTH AMERICA: SPINAL IMPLANTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 154
TABLE 107 NORTH AMERICA: SPINAL IMPLANTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 155
TABLE 108 NORTH AMERICA: THORACIC & LUMBAR FUSION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 155
TABLE 109 NORTH AMERICA: INTERBODY THORACIC & LUMBAR FUSION DEVICES MARKET, BY APPROACH, 2021–2028 (USD MILLION) 156
TABLE 110 NORTH AMERICA: INTERBODY THORACIC & LUMBAR FUSION DEVICES MARKET, BY MATERIAL, 2021–2028 (USD MILLION) 156
TABLE 111 NORTH AMERICA: CERVICAL FUSION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 157
TABLE 112 NORTH AMERICA: ANTERIOR CERVICAL FUSION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 157
TABLE 113 NORTH AMERICA: POSTERIOR CERVICAL FUSION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 157
TABLE 114 NORTH AMERICA: SPINE BIOLOGICS MARKET, BY TYPE, 2021–2028 (USD MILLION) 158
TABLE 115 NORTH AMERICA: VCF TREATMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 158
TABLE 116 NORTH AMERICA: SPINAL DECOMPRESSION DEVICES MARKET, BY PROCEDURE, 2021–2028 (USD MILLION) 159
TABLE 117 NORTH AMERICA: NON-FUSION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 159
TABLE 118 NORTH AMERICA: DYNAMIC STABILIZATION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 160
TABLE 119 NORTH AMERICA: ARTIFICIAL DISCS MARKET, BY TYPE, 2021–2028 (USD MILLION) 160
TABLE 120 NORTH AMERICA: SPINE BONE STIMULATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 160
TABLE 121 NORTH AMERICA: NONINVASIVE SPINE BONE STIMULATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 161
TABLE 122 NORTH AMERICA: SPINAL IMPLANTS MARKET, BY TYPE OF SURGERY, 2021–2028 (USD MILLION) 161
TABLE 123 NORTH AMERICA: SPINAL IMPLANTS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 161
TABLE 124 NORTH AMERICA: SPINAL IMPLANTS MARKET, BY END USER, 2021–2028 (USD MILLION) 162
10.2.2 US 162
10.2.2.1 US to dominate North American market 162
TABLE 125 US: SPINAL IMPLANTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 162
TABLE 126 US: THORACIC & LUMBAR FUSION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 163
TABLE 127 US: CERVICAL FUSION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 163
TABLE 128 US: SPINE BIOLOGICS MARKET, BY TYPE, 2021–2028 (USD MILLION) 164
TABLE 129 US: VCF TREATMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 164
TABLE 130 US: SPINAL DECOMPRESSION DEVICES MARKET, BY PROCEDURE, 2021–2028 (USD MILLION) 165
TABLE 131 US: NON-FUSION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 165
TABLE 132 US: SPINE BONE STIMULATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 165
10.2.3 CANADA 166
10.2.3.1 Inadequate reimbursement for spinal procedures to restrain market growth 166
TABLE 133 CANADA: SPINAL IMPLANTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 166
TABLE 134 CANADA: THORACIC & LUMBAR FUSION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 167
TABLE 135 CANADA: CERVICAL FUSION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 167
TABLE 136 CANADA: SPINE BIOLOGICS MARKET, BY TYPE, 2021–2028 (USD MILLION) 168
TABLE 137 CANADA: VCF TREATMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 168
TABLE 138 CANADA: SPINAL DECOMPRESSION DEVICES MARKET, BY PROCEDURE, 2021–2028 (USD MILLION) 169
TABLE 139 CANADA: NON-FUSION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 169
TABLE 140 CANADA: SPINE BONE STIMULATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 169
10.3 EUROPE 170
10.3.1 EUROPE: RECESSION IMPACT 170
TABLE 141 EUROPE: SPINAL IMPLANTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 170
TABLE 142 EUROPE: SPINAL IMPLANTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 171
TABLE 143 EUROPE: THORACIC & LUMBAR FUSION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 171
TABLE 144 EUROPE: INTERBODY THORACIC & LUMBAR FUSION DEVICES MARKET, BY APPROACH, 2021–2028 (USD MILLION) 172
TABLE 145 EUROPE: INTERBODY THORACIC & LUMBAR FUSION DEVICES MARKET, BY MATERIAL, 2021–2028 (USD MILLION) 172
TABLE 146 EUROPE: CERVICAL FUSION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 173
TABLE 147 EUROPE: ANTERIOR CERVICAL FUSION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 173
TABLE 148 EUROPE: POSTERIOR CERVICAL FUSION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 173
TABLE 149 EUROPE: SPINE BIOLOGICS MARKET, BY TYPE, 2021–2028 (USD MILLION) 174
TABLE 150 EUROPE: VCF TREATMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 174
TABLE 151 EUROPE: SPINAL DECOMPRESSION DEVICES MARKET, BY PROCEDURE, 2021–2028 (USD MILLION) 175
TABLE 152 EUROPE: NON-FUSION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 175
TABLE 153 EUROPE: DYNAMIC STABILIZATION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 176
TABLE 154 EUROPE: ARTIFICIAL DISCS MARKET, BY TYPE, 2021–2028 (USD MILLION) 176
TABLE 155 EUROPE: SPINE BONE STIMULATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 176
TABLE 156 EUROPE: NONINVASIVE SPINE BONE STIMULATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 177
TABLE 157 EUROPE: SPINAL IMPLANTS MARKET, BY TYPE OF SURGERY, 2021–2028 (USD MILLION) 177
TABLE 158 EUROPE: SPINAL IMPLANTS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 177
TABLE 159 EUROPE: SPINAL IMPLANTS MARKET, BY END USER, 2021–2028 (USD MILLION) 178
10.3.2 GERMANY 178
10.3.2.1 Germany to hold largest market share in Europe 178
TABLE 160 GERMANY: SPINAL IMPLANTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 178
TABLE 161 GERMANY: THORACIC & LUMBAR FUSION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 179
TABLE 162 GERMANY: CERVICAL FUSION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 179
TABLE 163 GERMANY: SPINE BIOLOGICS MARKET, BY TYPE, 2021–2028 (USD MILLION) 180
TABLE 164 GERMANY: VCF TREATMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 180
TABLE 165 GERMANY: SPINAL DECOMPRESSION DEVICES MARKET, BY PROCEDURE, 2021–2028 (USD MILLION) 181
TABLE 166 GERMANY: NON-FUSION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 181
TABLE 167 GERMANY: SPINE BONE STIMULATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 181
10.3.3 FRANCE 182
10.3.3.1 Rising healthcare expenditure to support market growth 182
TABLE 168 FRANCE: SPINAL IMPLANTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 182
TABLE 169 FRANCE: THORACIC & LUMBAR FUSION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 182
TABLE 170 FRANCE: CERVICAL FUSION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 183
TABLE 171 FRANCE: SPINE BIOLOGICS MARKET, BY TYPE, 2021–2028 (USD MILLION) 183
TABLE 172 FRANCE: VCF TREATMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 183
TABLE 173 FRANCE: SPINAL DECOMPRESSION DEVICES MARKET, BY PROCEDURE, 2021–2028 (USD MILLION) 184
TABLE 174 FRANCE: NON-FUSION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 184
TABLE 175 FRANCE: SPINE BONE STIMULATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 184
10.3.4 UK 185
10.3.4.1 Rising cost of spinal surgeries to hinder market growth 185
TABLE 176 UK: SPINAL IMPLANTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 185
TABLE 177 UK: THORACIC & LUMBAR FUSION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 186
TABLE 178 UK: CERVICAL FUSION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 186
TABLE 179 UK: SPINE BIOLOGICS MARKET, BY TYPE, 2021–2028 (USD MILLION) 187
TABLE 180 UK: VCF TREATMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 187
TABLE 181 UK: SPINAL DECOMPRESSION DEVICES MARKET, BY PROCEDURE, 2021–2028 (USD MILLION) 188
TABLE 182 UK: NON-FUSION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 188
TABLE 183 UK: SPINE BONE STIMULATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 188
10.3.5 ITALY 189
10.3.5.1 Demand for MIS to positively affect market growth 189
TABLE 184 ITALY: SPINAL IMPLANTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 189
TABLE 185 ITALY: THORACIC & LUMBAR FUSION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 190
TABLE 186 ITALY: CERVICAL FUSION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 190
TABLE 187 ITALY: SPINE BIOLOGICS MARKET, BY TYPE, 2021–2028 (USD MILLION) 191
TABLE 188 ITALY: VCF TREATMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 191
TABLE 189 ITALY: SPINAL DECOMPRESSION DEVICES MARKET, BY PROCEDURE, 2021–2028 (USD MILLION) 192
TABLE 190 ITALY: NON-FUSION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 192
TABLE 191 ITALY: SPINE BONE STIMULATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 192
10.3.6 SPAIN 193
10.3.6.1 Growing preference for MIS to support market growth 193
TABLE 192 SPAIN: SPINAL IMPLANTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 193
TABLE 193 SPAIN: THORACIC & LUMBAR FUSION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 194
TABLE 194 SPAIN: CERVICAL FUSION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 194
TABLE 195 SPAIN: SPINE BIOLOGICS MARKET, BY TYPE, 2021–2028 (USD MILLION) 195
TABLE 196 SPAIN: VCF TREATMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 195
TABLE 197 SPAIN: SPINAL DECOMPRESSION DEVICES MARKET, BY PROCEDURE, 2021–2028 (USD MILLION) 196
TABLE 198 SPAIN: NON-FUSION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 196
TABLE 199 SPAIN: SPINE BONE STIMULATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 196
10.3.7 REST OF EUROPE 197
TABLE 200 REST OF EUROPE: SPINAL IMPLANTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 197
TABLE 201 REST OF EUROPE: THORACIC & LUMBAR FUSION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 197
TABLE 202 REST OF EUROPE: CERVICAL FUSION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 198
TABLE 203 V: SPINE BIOLOGICS MARKET, BY TYPE, 2021–2028 (USD MILLION) 198
TABLE 204 REST OF EUROPE: VCF TREATMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 198
TABLE 205 REST OF EUROPE: SPINAL DECOMPRESSION DEVICES MARKET, BY PROCEDURE, 2021–2028 (USD MILLION) 199
TABLE 206 REST OF EUROPE: NON-FUSION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 199
TABLE 207 REST OF EUROPE: SPINE BONE STIMULATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 199

10.4 ASIA PACIFIC 200
10.4.1 ASIA PACIFIC: RECESSION IMPACT 200
FIGURE 26 ASIA PACIFIC: MARKET SNAPSHOT 201
TABLE 208 ASIA PACIFIC: SPINAL IMPLANTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 202
TABLE 209 ASIA PACIFIC: SPINAL IMPLANTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 202
TABLE 210 ASIA PACIFIC: THORACIC & LUMBAR FUSION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 203
TABLE 211 ASIA PACIFIC: INTERBODY THORACIC & LUMBAR FUSION DEVICES MARKET, BY APPROACH, 2021–2028 (USD MILLION) 203
TABLE 212 ASIA PACIFIC: INTERBODY THORACIC & LUMBAR FUSION DEVICES MARKET, BY MATERIAL, 2021–2028 (USD MILLION) 204
TABLE 213 ASIA PACIFIC: CERVICAL FUSION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 204
TABLE 214 ASIA PACIFIC: ANTERIOR CERVICAL FUSION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 204
TABLE 215 ASIA PACIFIC: POSTERIOR CERVICAL FUSION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 205
TABLE 216 ASIA PACIFIC: SPINE BIOLOGICS MARKET, BY TYPE, 2021–2028 (USD MILLION) 205
TABLE 217 ASIA PACIFIC: VCF TREATMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 205
TABLE 218 ASIA PACIFIC: SPINAL DECOMPRESSION DEVICES MARKET, BY PROCEDURE, 2021–2028 (USD MILLION) 206
TABLE 219 ASIA PACIFIC: NON-FUSION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 206
TABLE 220 ASIA PACIFIC: DYNAMIC STABILIZATION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 207
TABLE 221 ASIA PACIFIC: ARTIFICIAL DISCS MARKET, BY TYPE, 2021–2028 (USD MILLION) 207
TABLE 222 ASIA PACIFIC: SPINE BONE STIMULATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 207
TABLE 223 ASIA PACIFIC: NONINVASIVE SPINE BONE STIMULATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 208
TABLE 224 ASIA PACIFIC: SPINAL IMPLANTS MARKET, BY TYPE OF SURGERY, 2021–2028 (USD MILLION) 208
TABLE 225 ASIA PACIFIC: SPINAL IMPLANTS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 208
TABLE 226 ASIA PACIFIC: SPINAL IMPLANTS MARKET, BY END USER, 2021–2028 (USD MILLION) 209
10.4.2 JAPAN 209
10.4.2.1 Japan to dominate APAC market for spinal surgeries 209
TABLE 227 JAPAN: SPINAL IMPLANTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 210
TABLE 228 JAPAN: THORACIC & LUMBAR FUSION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 210
TABLE 229 JAPAN: CERVICAL FUSION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 211
TABLE 230 JAPAN: SPINE BIOLOGICS MARKET, BY TYPE, 2021–2028 (USD MILLION) 211
TABLE 231 JAPAN: VCF TREATMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 211
TABLE 232 JAPAN: SPINAL DECOMPRESSION DEVICES MARKET, BY PROCEDURE, 2021–2028 (USD MILLION) 212
TABLE 233 JAPAN: NON-FUSION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 212
TABLE 234 JAPAN: SPINE BONE STIMULATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 212
10.4.3 CHINA 213
10.4.3.1 Limited reimbursement coverage for spinal surgeries to affect market growth 213
TABLE 235 CHINA: SPINAL IMPLANTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 213
TABLE 236 CHINA: THORACIC & LUMBAR FUSION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 214
TABLE 237 CHINA: CERVICAL FUSION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 214
TABLE 238 CHINA: SPINE BIOLOGICS MARKET, BY TYPE, 2021–2028 (USD MILLION) 215
TABLE 239 CHINA: VCF TREATMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 215
TABLE 240 CHINA: SPINAL DECOMPRESSION DEVICES MARKET, BY PROCEDURE, 2021–2028 (USD MILLION) 216
TABLE 241 CHINA: NON-FUSION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 216
TABLE 242 CHINA: SPINE BONE STIMULATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 216
10.4.4 INDIA 217
10.4.4.1 Low surgical costs to support market growth 217
TABLE 243 INDIA: SPINAL IMPLANTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 217
TABLE 244 INDIA: THORACIC & LUMBAR FUSION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 218
TABLE 245 INDIA: CERVICAL FUSION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 218
TABLE 246 INDIA: SPINE BIOLOGICS MARKET, BY TYPE, 2021–2028 (USD MILLION) 219
TABLE 247 INDIA: VCF TREATMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 219
TABLE 248 INDIA: SPINAL DECOMPRESSION DEVICES MARKET, BY PROCEDURE, 2021–2028 (USD MILLION) 220
TABLE 249 INDIA: NON-FUSION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 220
TABLE 250 INDIA: SPINE BONE STIMULATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 220
10.4.5 AUSTRALIA 221
10.4.5.1 Uneven distribution of specialists to hinder market growth 221
TABLE 251 AUSTRALIA: SPINAL IMPLANTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 221
TABLE 252 AUSTRALIA: THORACIC & LUMBAR FUSION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 222
TABLE 253 AUSTRALIA: CERVICAL FUSION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 222
TABLE 254 AUSTRALIA: SPINE BIOLOGICS MARKET, BY TYPE, 2021–2028 (USD MILLION) 223
TABLE 255 AUSTRALIA: VCF TREATMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 223
TABLE 256 AUSTRALIA: SPINAL DECOMPRESSION DEVICES MARKET, BY PROCEDURE, 2021–2028 (USD MILLION) 224
TABLE 257 AUSTRALIA: NON-FUSION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 224
TABLE 258 AUSTRALIA: SPINE BONE STIMULATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 224
10.4.6 SOUTH KOREA 225
10.4.6.1 Growing medical tourism to favor demand for spinal implants 225
TABLE 259 SOUTH KOREA: SPINAL IMPLANTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 225
TABLE 260 SOUTH KOREA: THORACIC & LUMBAR FUSION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 226
TABLE 261 SOUTH KOREA: CERVICAL FUSION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 226
TABLE 262 SOUTH KOREA: SPINE BIOLOGICS MARKET, BY TYPE, 2021–2028 (USD MILLION) 227
TABLE 263 SOUTH KOREA: VCF TREATMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 227
TABLE 264 SOUTH KOREA: SPINAL DECOMPRESSION DEVICES MARKET, BY PROCEDURE, 2021–2028 (USD MILLION) 228
TABLE 265 SOUTH KOREA: NON-FUSION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 228
TABLE 266 SOUTH KOREA: SPINE BONE STIMULATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 228
10.4.7 REST OF ASIA PACIFIC 229
TABLE 267 REST OF ASIA PACIFIC: SPINAL IMPLANTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 229
TABLE 268 REST OF ASIA PACIFIC: THORACIC & LUMBAR FUSION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 230
TABLE 269 REST OF ASIA PACIFIC: CERVICAL FUSION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 230
TABLE 270 REST OF ASIA PACIFIC: SPINE BIOLOGICS MARKET, BY TYPE, 2021–2028 (USD MILLION) 231
TABLE 271 REST OF ASIA PACIFIC: VCF TREATMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 231
TABLE 272 REST OF ASIA PACIFIC: SPINAL DECOMPRESSION DEVICES MARKET, BY PROCEDURE, 2021–2028 (USD MILLION) 232
TABLE 273 REST OF ASIA PACIFIC: NON-FUSION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 232
TABLE 274 REST OF ASIA PACIFIC: SPINE BONE STIMULATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 233
10.5 LATIN AMERICA 233
10.5.1 LATIN AMERICA: RECESSION IMPACT 233
TABLE 275 LATIN AMERICA: SPINAL IMPLANTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 234
TABLE 276 LATIN AMERICA: SPINAL IMPLANTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 234
TABLE 277 LATIN AMERICA: THORACIC & LUMBAR FUSION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 235
TABLE 278 LATIN AMERICA: INTERBODY THORACIC & LUMBAR FUSION DEVICES MARKET, BY APPROACH, 2021–2028 (USD MILLION) 235
TABLE 279 LATIN AMERICA: INTERBODY THORACIC & LUMBAR FUSION DEVICES MARKET, BY MATERIAL, 2021–2028 (USD MILLION) 236
TABLE 280 LATIN AMERICA: CERVICAL FUSION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 236
TABLE 281 LATIN AMERICA: ANTERIOR CERVICAL FUSION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 236
TABLE 282 LATIN AMERICA: POSTERIOR CERVICAL FUSION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 237
TABLE 283 LATIN AMERICA: SPINE BIOLOGICS MARKET, BY TYPE, 2021–2028 (USD MILLION) 237
TABLE 284 LATIN AMERICA: VCF TREATMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 237
TABLE 285 LATIN AMERICA: SPINAL DECOMPRESSION DEVICES MARKET, BY PROCEDURE, 2021–2028 (USD MILLION) 238
TABLE 286 LATIN AMERICA: NON-FUSION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 238
TABLE 287 LATIN AMERICA: DYNAMIC STABILIZATION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 239
TABLE 288 LATIN AMERICA: ARTIFICIAL DISCS MARKET, BY TYPE, 2021–2028 (USD MILLION) 239
TABLE 289 LATIN AMERICA: SPINE BONE STIMULATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 239
TABLE 290 LATIN AMERICA: NONINVASIVE SPINE BONE STIMULATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 240
TABLE 291 LATIN AMERICA: SPINAL IMPLANTS MARKET, BY TYPE OF SURGERY, 2021–2028 (USD MILLION) 240
TABLE 292 LATIN AMERICA: SPINAL IMPLANTS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 240
TABLE 293 LATIN AMERICA: SPINAL IMPLANTS MARKET, BY END USER, 2021–2028 (USD MILLION) 241
10.5.2 BRAZIL 241
10.5.2.1 Brazil to dominate LATAM market 241
TABLE 294 BRAZIL: SPINAL IMPLANTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 241
TABLE 295 BRAZIL: THORACIC & LUMBAR FUSION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 242
TABLE 296 BRAZIL: CERVICAL FUSION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 242
TABLE 297 BRAZIL: SPINE BIOLOGICS MARKET, BY TYPE, 2021–2028 (USD MILLION) 243
TABLE 298 BRAZIL: VCF TREATMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 243
TABLE 299 BRAZIL: SPINAL DECOMPRESSION DEVICES MARKET, BY PROCEDURE, 2021–2028 (USD MILLION) 244
TABLE 300 BRAZIL: NON-FUSION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 244
TABLE 301 BRAZIL: SPINE BONE STIMULATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 244
10.5.3 MEXICO 245
10.5.3.1 Fragmented healthcare system to create challenges for market players 245
TABLE 302 MEXICO: SPINAL IMPLANTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 245
TABLE 303 MEXICO: THORACIC & LUMBAR FUSION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 245
TABLE 304 MEXICO: CERVICAL FUSION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 246
TABLE 305 MEXICO: SPINE BIOLOGICS MARKET, BY TYPE, 2021–2028 (USD MILLION) 246
TABLE 306 MEXICO: VCF TREATMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 246
TABLE 307 MEXICO: SPINAL DECOMPRESSION DEVICES MARKET, BY PROCEDURE, 2021–2028 (USD MILLION) 247
TABLE 308 MEXICO: NON-FUSION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 247
TABLE 309 MEXICO: SPINE BONE STIMULATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 247
10.5.4 REST OF LATIN AMERICA 248
TABLE 310 REST OF LATIN AMERICA: SPINAL IMPLANTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 248
TABLE 311 REST OF LATIN AMERICA: THORACIC & LUMBAR FUSION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 249
TABLE 312 REST OF LATIN AMERICA: CERVICAL FUSION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 249
TABLE 313 REST OF LATIN AMERICA: SPINE BIOLOGICS MARKET, BY TYPE, 2021–2028 (USD MILLION) 250
TABLE 314 REST OF LATIN AMERICA: VCF TREATMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 250
TABLE 315 REST OF LATIN AMERICA: SPINAL DECOMPRESSION DEVICES MARKET, BY PROCEDURE, 2021–2028 (USD MILLION) 251
TABLE 316 REST OF LATIN AMERICA: NON-FUSION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 251
TABLE 317 REST OF LATIN AMERICA: SPINE BONE STIMULATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 252
10.6 MIDDLE EAST & AFRICA 252
10.6.1 MEA TO OFFER PROMISING OPPORTUNITIES FOR PLAYERS 252
10.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT 252
TABLE 318 MIDDLE EAST & AFRICA: SPINAL IMPLANTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 253
TABLE 319 MIDDLE EAST & AFRICA: THORACIC & LUMBAR FUSION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 253
TABLE 320 MIDDLE EAST & AFRICA: INTERBODY THORACIC & LUMBAR FUSION DEVICES MARKET, BY APPROACH, 2021–2028 (USD MILLION) 254
TABLE 321 MIDDLE EAST & AFRICA: INTERBODY THORACIC & LUMBAR FUSION DEVICES MARKET, BY MATERIAL, 2021–2028 (USD MILLION) 254
TABLE 322 MIDDLE EAST & AFRICA: CERVICAL FUSION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 255
TABLE 323 MIDDLE EAST & AFRICA: ANTERIOR CERVICAL FUSION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 255
TABLE 324 MIDDLE EAST & AFRICA: POSTERIOR CERVICAL FUSION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 255
TABLE 325 MIDDLE EAST & AFRICA: SPINE BIOLOGICS MARKET, BY TYPE, 2021–2028 (USD MILLION) 256
TABLE 326 MIDDLE EAST & AFRICA: VCF TREATMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 256
TABLE 327 MIDDLE EAST & AFRICA: SPINAL DECOMPRESSION DEVICES MARKET, BY PROCEDURE, 2021–2028 (USD MILLION) 257
TABLE 328 MIDDLE EAST & AFRICA: NON-FUSION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 257
TABLE 329 MIDDLE EAST & AFRICA: DYNAMIC STABILIZATION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 258
TABLE 330 MIDDLE EAST & AFRICA: ARTIFICIAL DISCS MARKET, BY TYPE, 2021–2028 (USD MILLION) 258
TABLE 331 MIDDLE EAST & AFRICA: SPINE BONE STIMULATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 258
TABLE 332 MIDDLE EAST & AFRICA: NONINVASIVE SPINE BONE STIMULATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 259
TABLE 333 MIDDLE EAST & AFRICA: SPINAL IMPLANTS MARKET, BY TYPE OF SURGERY, 2021–2028 (USD MILLION) 259
TABLE 334 MIDDLE EAST & AFRICA: SPINAL IMPLANTS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 259
TABLE 335 MIDDLE EAST & AFRICA: SPINAL IMPLANTS MARKET, BY END USER, 2021–2028 (USD MILLION) 260
10.6.3 GCC COUNTRIES 260
11 COMPETITIVE LANDSCAPE 261
11.1 OVERVIEW 261
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 261
11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY SPINAL IMPLANT PLAYERS 261
11.3 REVENUE SHARE ANALYSIS 263
FIGURE 27 REVENUE SHARE ANALYSIS OF TOP PLAYERS IN SPINAL IMPLANTS MARKET, 2018–2022 (USD MILLION) 263
11.4 MARKET SHARE ANALYSIS 264
11.4.1 GLOBAL SPINAL IMPLANTS/SURGICAL DEVICES MARKET SHARE, BY KEY PLAYER, 2022 264
FIGURE 28 SPINAL IMPLANTS/SURGICAL DEVICES MARKET SHARE ANALYSIS, 2022 264
11.4.2 GLOBAL SPINE BIOLOGICS MARKET SHARE, BY KEY PLAYER, 2022 264
FIGURE 29 SPINE BIOLOGICS MARKET SHARE ANALYSIS, 2022 264
11.4.3 GLOBAL SPINE BONE STIMULATORS MARKET SHARE, BY KEY PLAYER, 2022 265
FIGURE 30 SPINE BONE STIMULATORS MARKET SHARE ANALYSIS, 2022 265
FIGURE 31 SPINAL IMPLANTS MARKET (2022) 266
11.5 COMPANY EVALUATION MATRIX 267
11.5.1 STARS 267
11.5.2 EMERGING LEADERS 267
11.5.3 PERVASIVE PLAYERS 267
11.5.4 PARTICIPANTS 267
FIGURE 32 SPINAL IMPLANTS MARKET: COMPANY EVALUATION MATRIX, 2022 268
11.5.5 COMPANY FOOTPRINT 268
TABLE 336 PRODUCT FOOTPRINT (17 COMPANIES) 268
TABLE 337 REGIONAL FOOTPRINT (17 COMPANIES) 269
TABLE 338 COMPANY FOOTPRINT (17 COMPANIES) 270
11.6 STARTUP/SME EVALUATION MATRIX 270
11.6.1 PROGRESSIVE COMPANIES 270
11.6.2 STARTING BLOCKS 271
11.6.3 RESPONSIVE COMPANIES 271
11.6.4 DYNAMIC COMPANIES 271
FIGURE 33 SPINAL IMPLANTS MARKET: STARTUP/SME EVALUATION MATRIX, 2022 271
11.6.5 COMPANY BENCHMARKING 272
TABLE 339 SPINAL IMPLANTS MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS 272
TABLE 340 SPINAL IMPLANTS MARKET: COMPETITIVE BENCHMARKING OF STARTUP/SME PLAYERS 272
11.7 COMPETITIVE SCENARIOS AND TRENDS 273
TABLE 341 KEY PRODUCT LAUNCHES & APPROVALS (JANUARY 2021 TO OCTOBER 2023) 273
TABLE 342 KEY DEALS 274
12 COMPANY PROFILES 275
12.1 KEY PLAYERS 275
(Business overview, Services/Solutions offered, Recent developments, MnM view, Right to win, Strategic choices made, and Weaknesses and Competitive threats)*
12.1.1 MEDTRONIC PLC 275
TABLE 343 MEDTRONIC PLC: COMPANY OVERVIEW 275
FIGURE 34 MEDTRONIC PLC: COMPANY SNAPSHOT (2023) 276
12.1.2 JOHNSON & JOHNSON MEDTECH 280
TABLE 344 JOHNSON & JOHNSON MEDTECH: COMPANY OVERVIEW 280
FIGURE 35 JOHNSON & JOHNSON MEDTECH: COMPANY SNAPSHOT (2022) 281
12.1.3 NUVASIVE, INC. 285
TABLE 345 NUVASIVE, INC: COMPANY OVERVIEW 285
FIGURE 36 NUVASIVE, INC: COMPANY SNAPSHOT (2022) 286
12.1.4 STRYKER CORPORATION 289
TABLE 346 STRYKER CORPORATION: COMPANY OVERVIEW 289
FIGURE 37 STRYKER CORPORATION: COMPANY SNAPSHOT (2022) 290
12.1.5 GLOBUS MEDICAL, INC. 294
TABLE 347 GLOBUS MEDICAL, INC.: COMPANY OVERVIEW 294
FIGURE 38 GLOBUS MEDICAL, INC.: COMPANY SNAPSHOT (2022) 295
12.1.6 ZIMMER BIOMET HOLDINGS, INC. 297
TABLE 348 ZIMMER BIOMET HOLDINGS, INC.: COMPANY OVERVIEW 297
FIGURE 39 ZIMVIE, INC.: COMPANY SNAPSHOT (2022) 298
12.1.7 ORTHOFIX INTERNATIONAL N.V. 300
TABLE 349 ORTHOFIX INTERNATIONAL N.V.: COMPANY OVERVIEW 300
FIGURE 40 ORTHOFIX INTERNATIONAL N.V.: COMPANY SNAPSHOT (2022) 301
12.1.8 ULRICH GMBH & CO. KG 303
TABLE 350 ULRICH GMBH & CO. KG: COMPANY OVERVIEW 303
12.1.9 B. BRAUN MELSUNGEN AG 304
FIGURE 41 B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT (2022) 305
12.1.10 INTEGRA LIFESCIENCES HOLDINGS CORPORATION 306
TABLE 351 INTEGRA LIFESCIENCES HOLDINGS CORPORATION: COMPANY OVERVIEW 306
FIGURE 42 INTEGRA LIFESCIENCES HOLDINGS CORPORATION: COMPANY SNAPSHOT (2023) 307
12.1.11 BOSTON SCIENTIFIC CORPORATION 308
TABLE 352 BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW 308
FIGURE 43 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2022) 309
12.1.12 ABBOTT LABORATORIES 311
TABLE 353 ABBOTT LABORATORIES: COMPANY OVERVIEW 311
FIGURE 44 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2022) 312
12.1.13 SPINEART 313
TABLE 354 SPINEART: COMPANY OVERVIEW 313
12.1.14 CENTINEL SPINE LLC 315
TABLE 355 CENTINEL SPINE LLC: BUSINESS OVERVIEW 315
12.1.15 PREMIA SPINE 316
TABLE 356 PREMIA SPINE: BUSINESS OVERVIEW 316
12.1.16 EXACTECH, INC. 317
TABLE 357 EXACTECH, INC.: BUSINESS OVERVIEW 317
12.1.17 LIFE SPINE, INC. 318
TABLE 358 LIFE SPINE, INC.: BUSINESS OVERVIEW 318
12.1.18 ATEC SPINE 320
TABLE 359 ATEC SPINE: BUSINESS OVERVIEW 320
FIGURE 45 ATEC SPINE: COMPANY SNAPSHOT (2022) 320
12.2 OTHER PLAYERS 322
12.2.1 KUROS BIOSCIENCES LTD. 322
12.2.2 BIOVENTUS LLC 322
12.2.3 COLFAX CORPORATION 323
12.2.4 AESCULAP INC. 323
12.2.5 IMPLANET 324
12.2.6 CAMBER SPINE TECHNOLOGIES 324
12.2.7 CAPTIVA SPINE, INC. 325
12.2.8 MEDACTA INTERNATIONAL 325
12.2.9 AURORA SPINE CORPORATION 326
*Details on Business overview, Services/Solutions offered, Recent developments, MnM view, Right to win, Strategic choices made, and Weaknesses and Competitive threats might not be captured in case of unlisted companies.
13 APPENDIX 327
13.1 DISCUSSION GUIDE 327
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 332
13.3 CUSTOMIZATION OPTIONS 334
13.4 RELATED REPORTS 334
13.5 AUTHOR DETAILS 335

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 脊椎インプラント・手術機器の世界市場（2023-2028）
  • 後部胸部及び腰部脊椎固定システムの世界市場2022-2028：腰椎固定、胸椎固定
  • 脊椎固定装置の世界市場（2023-2028）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(MD1173-24 )"脊椎インプラントの世界市場予測（～2028）：製品別、用途別、手術別、地域別" (英文：Spinal Implants Market by Product (Devices (Thoracic, Cervical, Interbody Fusion, Spinal Non-Fusion), Biologics, Stimulators), Application (VCF, Spinal Decompression, Fusion, Non-Fusion), Surgery (Open, MIS), Region & Customer Unmet Need Forecast to 2028)はMarketsandMarkets社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。